We partner with visionary health-tech companies and founders to accelerate growth across emerging and frontier markets.
About MariamTek Inc.
MariamTek Inc., an Illinois-based health-tech accelerator, is a strategic investment and advisory platform focused on healthcare innovation.
We connect breakthrough health-tech ventures with the right capital, partners, and regulatory pathways to scale globally — with active investments and ecosystem leadership across the GCC, North America, and emerging markets.
MariamTek stands at the forefront of vaccine delivery through its strategic partnerships with renowned vaccine and medication delivery platform manufacturers, leads next-generation diabetes care through physiological insulin resensitization, and embraces frontier technologies that redefine the future of health.
Who We Are
MariamTek Inc. is a strategic investment and advisory platform focused on healthcare innovation. We connect breakthrough healthtech with the right capital, partners, and regulatory pathways to scale globally. We are active investors and ecosystem builders in the GCC, North America, and emerging markets.
What We Do
Venture Strategy & Advisory
We help early-stage and growth healthtech ventures refine their strategy, identify viable markets, and prepare for regulatory scrutiny. From go-to-market planning to operational setup and pitch refinement, we serve as a hands-on extension of your founding team.
Capital & Access
Through direct investment and co-investment structures, we open doors to aligned capital across sovereign funds, family offices, and venture firms. We don’t just fund companies — we connect them with stakeholders who accelerate scale.
Global Market Expansion
We offer on-ground expertise for market entry in the UAE and broader GCC region, while also supporting North American commercialization and Asia expansion. Our cross-border team aligns strategy with local dynamics and execution.
Areas of Focus
Regenerative Medicine (incl. Stem Cell Therapy)
MariamTek is pioneering the application of regenerative science in both human and veterinary medicine. Our current efforts include stem cell therapy programs for camels in the GCC — an innovation that bridges tradition with cutting-edge care.
Precision Diagnostics
We invest in technologies that improve early detection and patient outcomes through next-generation diagnostics. From AI-driven imaging to mobile biosensors, MariamTek supports tools that enable faster, more accurate diagnoses.
Vaccine Innovation
As the exclusive partner for a renowned vaccine delivery platform in the region, we champion pain-free, patch-based vaccine delivery that revolutionizes how populations are immunized. Our focus is on health equity, pandemic resilience, and public health scale.
Remote Patient Monitoring
MariamTek supports platforms that empower patients and providers to manage care outside traditional clinical settings. These tools offer scalable solutions for chronic disease, post-op care, and preventative health.
AI in Clinical Decision Support
We collaborate with AI ventures that support clinicians in making timely, personalized, and data-backed medical decisions. From early triage tools to explainable diagnostics, our partners are shaping the intelligent hospital of tomorrow.
Smart Cities – Non-invasive diagnostics and infrastructure intelligence
iLamp combines advanced sensor technologies with smart infrastructure to deliver early warning diagnostics — both environmental and human. With capabilities to detect hidden pathologies, underground contaminants, and airborne health risks, iLamp supports safer cities, smarter healthcare environments, and defense-grade medical screening infrastructure.
Use cases include border health screening, urban safety monitoring, and critical site security with embedded health detection layers.
Electronic Printing for Medical Purposes
Through our stake in I4 Technologies, we are helping to develop electronic printing platforms that produce flexible diagnostic devices, wearable sensors, and other printed medical-grade electronics.
Why MariamTek?
✅ 25+ Years of Healthtech Scaling Experience
Proven track record guiding early-stage innovations into regulated markets and commercial success stories worldwide.
🌍 Presence in the UAE, U.S., and Asia
Our cross-border platform ensures strategic positioning across global health hubs and emerging high-growth regions.
🧠 Expert Advisory Team
Seasoned leaders in go-to-market strategy, clinical operations, regulatory navigation, and venture capital — from first pilot to full-scale rollout.
🏛️ Deep Institutional Access
Longstanding relationships with ministries of health, leading universities, sovereign investment arms, and private sector buyers across multiple continents.
MariamTek & 360Disruption, 2 Names, 1 Mission
At the heart of breakthrough health-tech innovation is not just invention — but execution. That’s where the strategic alliance between MariamTek Inc. and 360Disruption FZE comes in.
Together, we unite deep clinical and investment expertise with regional execution power to bring transformative medical technologies to life — starting in the GCC and scaling globally.
MariamTek brings over two decades of experience in healthcare venture building, with a portfolio spanning regenerative medicine, diagnostics, smart delivery systems, and digital health.
360Disruption, based in the UAE, is MariamTek’s operational and regulatory partner in the Gulf — enabling fast-track approvals, local licensing, government relations, and commercial rollout.
Our alliance is built around a clear purpose:
Accelerate time to market for high-impact innovations
Align ventures with GCC priorities like Vision 2030, sustainability, and health equity
Create shared value through joint ventures, licensing, and commercial partnerships
From stem cell therapy for veterinary care to next-generation vaccine patches and diagnostic platforms, we’re building the bridge between clinical promise and real-world scale.
Innovation needs a launchpad. Together, we’ve built one.
🚀 What We Offer:
Unmatched Expertise
Clinical innovators, regulatory veterans, and commercialization leaders working hand-in-hand.
Global Market Access
From regulatory entry in the UAE and GCC to clinical trials and commercialization in the U.S. and Asia — we’ve done it, and we do it again.
Full-Stack GTM Execution
From strategy decks and investor readiness to on-ground sales development and partnerships — 360Disruption handles the roll-out so founders can focus on tech and care.
Regulatory Acceleration
Through our ecosystem in the UAE — including hospitals, ministries, and academic centers — we expedite what usually takes years.
Deep Ecosystem Connectivity
Access to sovereign wealth funds, family offices, public health leadership, and global commercialization routes.
💡 Who We Help:
Founders with disruptive med-tech or biotech
U.S. companies ready to enter the GCC
GCC initiatives looking to localize global innovation
Investors seeking vetted, scalable health-tech assets
MariamTek: Where Health Innovation Meets Market Access
As a strategic health-tech accelerator, MariamTek transforms breakthrough technologies into real-world solutions. With a growing portfolio in regenerative medicine, vaccine delivery, and AI diagnostics — and an active footprint across the GCC, U.S., and Asia — licensing MariamTek means backing scalable, science-driven ventures aligned with global health priorities.
By licensing MariamTek through ILOCX.com — a trusted platform for licensing and revenue-sharing with high-impact growth companies — you’re gaining early access to a company positioned at the intersection of healthcare innovation and emerging markets.
Featured Partnerships
Smart patch vaccine delivery
A delivery platform technology revolutionizes the way vaccines are administered by using a single-dose patch for pain-free delivery. MariamTek has supported their expansion into the Middle East, aligning the innovation with regional health security priorities and funding opportunities.
Stem cell therapy for veterinary use
With a novel application of regenerative science for camels and other high-value mammals, this company is pioneering animal healthcare in the Gulf. Through our partnership, we are enabling clinical trials, regulatory setup, and early commercialization strategies.
Physiologic Insulin Resensitization (PIR)
This FDA-approved approach to diabetes care is being introduced into the GCC through a licensing and operational rollout with MariamTek, aiming to combat the region’s rising metabolic disease burden with proven, patient-first innovation.
Non-invasive diagnostic & security scanning
Company’s sensor technology can detect hidden pathologies and even underground resources. MariamTek is advising on licensing structures, international deployment, and downstream commercialization pathways.
Let’s Build the Future of Healthcare Together
At MariamTek, we’re more than just investors—we’re partners in innovation. If you’re a healthtech founder with a groundbreaking idea, a company ready to scale, or an organization seeking strategic collaboration, we’re here to help you navigate the complexities of the healthcare landscape.
With our deep expertise in healthcare innovation, regulatory pathways, and market access, we empower visionary companies to transform ideas into impactful solutions.
Ready to make a difference?
Ready to Partner?
Let’s bring impactful healthtech to the world — together.
